ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: TH-PO1040

A Novel Approach in Differential Diagnosis of Primary Glomerulonephritis Using the Decision Tree Algorithm Model Based on Biomarkers Panel

Session Information

Category: Glomerular Diseases

  • 1203 Glomerular Diseases: Clinical, Outcomes, and Trials

Authors

  • Saganova, Elena, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russian Federation
  • Galkina, Olga, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russian Federation
  • Sipovskii, Vasiliy, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russian Federation
  • Smirnov, Alexey, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg, Russian Federation
Background

Recent studies showed that measurement of various biomarkers (BM) can be useful in differential diagnosis of some primary glomerulonephritis (GN) forms. Our aim was to develop an algorithm for differential diagnosis of primary GN based on BM panel using decision tree learning approach.

Methods

74 patients [39 male, age Me (min 18; max 83) – 37,5 (25; 54) years] with biopsy proven primary GN and without AKI, infectious diseases, severe heart failure, respiratory insufficiency, cancer, abnormal thyroid status, treatment with prednisolone more than 10 mg/per day were included in the study. Based on the results of kidney biopsy (KB) in 7% of cases minimal change disease (MCD) was diagnosed, in 27% – FSGS, in 27% – membranous nephropathy (MN), in 39% – IgA-nephropathy. BM were measured in the morning on the day of KB: serum creatinine(sCr), albumin(sAlb), CysC(sCysC), 24-hour total protein(24hTP), urinary (24-hour collection) cystatin C(uCysC), transferrin(uTr), IgG(uIgG), α1-microglobulin(uα1-mg), β2-microglobulin(uβ2-mg), serum/urine magnesium. The Classification and Regression Trees (CART) learning algorithm with FACT-style direct stopping as pruning criteria was used to create a model for differential diagnosis. Complete machine learning, statistical analysis were performed with Statistica v.12.

Results

A decision tree algorithm was developed including ten predictor variables: age, sAlb, uTrans, t24hTP, sCysC, uIgG, uβ2-mg, sCr, uα1-mg, EFMg. This algorithm accurately classified patients with MCD in 100% cases (5 out of 5 cases), FSGS - 80% (16/20 cases), MN - 85% (17/20 cases), IgA-nephropathy - 96,6% (28/29 cases) (Figure 1).

Conclusion

A “decision tree” algorithm based on age and few urinary, serum BM can be a powerful diagnostic tool in differential diagnosis of primary GN. Application of this algorithm allows to evaluate patients with high risk progression of CKD, identify treatment targets before or instead of KB.

Funding

  • Government Support - Non-U.S.